BPharm Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 04470974

		2024		2023
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		76		95

			76		95
CURRENT ASSETS
Debtors	5	148		37
Cash at bank and in hand		8,102		16,098

		8,250		16,135
Creditors: Amounts Falling Due Within One Year	6	(4,727 )		(12,747 )

NET CURRENT ASSETS (LIABILITIES)			3,523		3,388

TOTAL ASSETS LESS CURRENT LIABILITIES			3,599		3,483

NET ASSETS			3,599		3,483

CAPITAL AND RESERVES
Called up share capital	7		1		1
Profit and Loss Account			3,598		3,482

SHAREHOLDERS' FUNDS			3,599		3,483

Page 1

Page 2

BPharm Limited

Balance Sheet (continued)

As At 31 December 2024

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mrs Bhavni Bajwa

Director

15th July 2025

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

BPharm Limited Registered number 04470974 is a limited by shares company incorporated in England & Wales. The Registered Office is 10 Coledale Drive, Stanmore, Middlesex, HA7 2QF.

Please note that the comparative figures are for a 6 month period from 1st July 2015 to 31st December 2015.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery

20% Reducing Balance

2.4. Registrar Filing Requirements

The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 1 (2023: 1)

4. Tangible Assets

	Plant & Machinery
	£
Cost
As at 1 January 2024	4,077

As at 31 December 2024	4,077

Depreciation
As at 1 January 2024	3,982
Provided during the period	19

As at 31 December 2024	4,001

...CONTINUED

Page 3

Page 4

BPharm Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2024

Net Book Value
As at 31 December 2024	76

As at 1 January 2024	95

5. Debtors

	2024	2023
	£	£
Due within one year
Prepayments and accrued income	39	37
Scuderia Famiglia Loan Account	109	-

	148	37

6. Creditors: Amounts Falling Due Within One Year

	2024	2023
	£	£
Trade creditors	137	22
Mayfair One Ltd Loan Account	972	-
Accruals and deferred income	832	777
Director's loan account	2,786	11,948

	4,727	12,747

7. Share Capital

	2024	2023
Allotted, called up and fully paid	£	£
1 Ordinary Shares of £ 1.00 each	1	1

8. Directors Advances, Credits and Guarantees

Dividends paid to directors

9. Dividends

10. Ultimate Controlling Party

The company's ultimate controlling party is Mrs Bhavnivenichand Shah by virtue of her ownership of 100% of the issued share capital in the company.

Page 4